Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

HIV (human immunodeficiency virus) is a virus that weakens the immune system and hinders the body’s ability to fight disease. Without treatment, HIV could lead to the potentially fatal diagnosis of AIDS (acquired immune deficiency syndrome). The AIDS epidemic began in the 1980s and millions of lives have been lost since it was first discovered. Over the decades, advances in technology and medical capabilities have brought more advanced HIV treatments. 

John Frater and Naomi Ferret-Cohen in the Garden

John Frater and Naomi Ferret-Cohen in the Garden

Professor John Frater (Nuffield Department of Medicine) is co-PI and Scientific Lead for the CHERUB Co-operative. His research focuses on quantification of viral reservoirs, sequence analysis by standard and next generation models, immunology (predominantly looking at the role of CTL in remission strategies) and more fundamental research into new approaches to eradication such as nanotechnology.

Listen to Professor Frater discuss his research on these platforms: 

Podcast: Can you cure HIV?

Professor Frater discusses the question 'Can we cure HIV?' as part of the Oxford Sparks 'Big Questions' podcast series - listen to the podcast




Facebook show advertisment

You can also watch Professor Frater discuss his research in two Facebook Lives from the RHS Chelsea Flower show - watch his interview.




A female journalist interviewing Prof Frater

Professor Frater on the question: 'Can we eradicate HIV?' as part of the Nuffield Department of Medicine 'Meet our researchers' podcasts - watch the interview.